A phase 4 study of nilotinib in Korean patients with Philadelphia chromosome‐positive chronic myeloid leukemia in chronic phase: ENESTKorea

Although nilotinib has improved efficacy compared to imatinib, suboptimal response and intolerable adverse events (AEs) limit its effectiveness in many patients with chronic myeloid leukemia in chronic phase (CML‐CP). We investigated the 2‐year efficacy and safety of nilotinib and their relationship...

Cur síos iomlán

Na minha lista:
Sonraí Bibleagrafaíochta
Foilsithe in:Cancer Med
Main Authors: Shin, Junghoon, Koh, Youngil, Yoon, Seo Hyun, Cho, Joo‐Youn, Kim, Dae‐Young, Lee, Kyoo‐Hyung, Kim, Hyeong‐Joon, Ahn, Jae‐Sook, Kim, Yeo‐Kyeoung, Park, Jinny, Sohn, Sang‐Kyun, Moon, Joon Ho, Lee, Yoo Jin, Yoon, Seonghae, Lee, Jeong‐Ok, Cheong, June‐Won, Kim, Kyoung Ha, Kim, Sung‐Hyun, Kim, Hoon‐Gu, Kim, Hawk, Nam, Seung‐Hyun, Do, Young Rok, Park, Sang‐Gon, Park, Seong Kyu, Bae, Sung Hwa, Song, Hun Ho, Shin, Dong‐Yeop, Oh, Doyeun, Kim, Min Kyoung, Jung, Chul Won, Park, Seonyang, Kim, Inho
Formáid: Artigo
Teanga:Inglês
Foilsithe: John Wiley and Sons Inc. 2018
Ábhair:
Clinical Cancer Research
Rochtain Ar Líne:https://ncbi.nlm.nih.gov/pmc/articles/PMC5943463/
https://ncbi.nlm.nih.gov/pubmed/29577674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1450
Clibeanna: Cuir Clib Leis
Gan Chlibeanna, Bí ar an gcéad duine leis an taifead seo a chlibeáil!

Míreanna Comhchosúla